Compare CBT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBT | LGND |
|---|---|---|
| Founded | 2019 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.7B |
| IPO Year | 1994 | N/A |
| Metric | CBT | LGND |
|---|---|---|
| Price | $67.53 | $198.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $70.00 | ★ $245.00 |
| AVG Volume (30 Days) | ★ 379.7K | 149.2K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $3,713,000,000.00 | N/A |
| Revenue This Year | N/A | $0.74 |
| Revenue Next Year | $2.89 | $19.04 |
| P/E Ratio | ★ $49.47 | $76.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $58.33 | $93.58 |
| 52 Week High | $84.89 | $227.92 |
| Indicator | CBT | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 32.71 | 49.78 |
| Support Level | $65.48 | $198.52 |
| Resistance Level | $69.75 | $207.72 |
| Average True Range (ATR) | 2.11 | 10.01 |
| MACD | -1.05 | 1.53 |
| Stochastic Oscillator | 12.20 | 41.26 |
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.